Low doses of ketamine didn’t reduce delirium, postoperative pain, or other complications related to major surgeries. The results challenge a common practice.
Detailed views of two membrane receptors involved in controlling blood glucose reveal new insights into important drug targets for diabetes and obesity.
May 12, 2017 —
A study with mice found that a protein called FOXO3 is involved in recovery from noise-induced hearing loss. The results suggest new potential treatments approaches.
May 12, 2017 —
Scientists identified an enzyme in animal studies whose activity promotes weight gain and the loss of fitness starting in mid-life. The findings could lead to improved weight-loss drugs.
May 12, 2017 —
Researchers created a 3-D brain development model that revealed a defect in how neurons migrate to cause Timothy syndrome. The results demonstrate a way to study personalized brain development and disease.
May 2, 2017 —
For people with type 1 diabetes, researchers suggest a new eye exam schedule based on their individual risk level for diabetic retinopathy, a vision-threatening eye disease.
May 2, 2017 —
A wearable device measures salt levels in sweat to diagnose patients with cystic fibrosis. The device could be adapted for other uses as well.
May 2, 2017 —
A series of experiments with men in a space flight program and mice overturns long-held beliefs about thirst and reveals how the body controls its salt and water balance.
April 25, 2017 —
Researchers found a rise in the rate of new cases of diabetes in youths under the age of 20. Understanding why certain youths are more at risk may help inform future prevention and treatment efforts.
April 25, 2017 —
A gene-silencing drug improved symptoms in mouse models of ataxia and amyotrophic lateral sclerosis. The results suggest a possible therapy for these untreatable neurological diseases.
April 25, 2017 —
Scientists developed a CRISPR-based tool that can detect tiny amounts of Zika and Dengue virus, distinguish pathogenic bacteria, and identify DNA variations.
